Viewing Study NCT06481436



Ignite Creation Date: 2024-07-17 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06481436
Status: RECRUITING
Last Update Posted: 2024-07-01
First Post: 2024-06-11

Brief Title: Use of Artificial Intelligence by Urogynecologic Patients
Sponsor: Hartford Hospital
Organization: Hartford Hospital

Study Overview

Official Title: Use of Artificial Intelligence by Patients for Understanding of Diagnosis of Urogynecologic Conditions and Its Role in Treatment Decisions
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn about how Urogynecology patients use Artificial Intelligence AI Chatbots like ChatGPT and how it affects healthcare decision making The main questions it aims to answer are

How does the AI Chatbot affect participants understanding of diagnoses and participant satisfaction with a urogynecology consultation
How accurate is the chatbot-provided diagnosis and counseling information Participants will be asked to use the ChatGPT chatbot and ask it questions about the main problem the participant is seeing the doctor for and will also be asked to fill out some questionnaires

Researchers will compare using the Chatbot before the visit after the visit or not at all to see if the way participants understand the information changes based on timing of use
Detailed Description: Artificial Intelligence AI in medicine and the use of machine learning to improve patient care and outcomes is a quickly developing field Interest is building in the use and accuracy of AI chatbot programs such as ChatGPT for patient diagnosis and counseling A recent study of Chat GPT accuracy compared with patient pamphlets about pelvic organ prolapse found comparable accuracy and completenessGiven the novelty of this field no current literature exists regarding the use of AI chatbot technology for patient care and patient counseling in Urogynecology

This will be a single-center prospective randomized non-blinded study examining patient use of AI Chatbot technology Chat GPT4 at initial visits to supplement understanding of urogynecologic problems The primary aim of this study is to investigate the effect of use of an AI Chatbot platform on patient understanding of disease processes and treatment options prior to or following a consult with a urogynecologist at the initial visit The secondary aims are to evaluate the accuracy of the chatbot-provided diagnosis for participants applicable through randomization and counseling information and to evaluate patient satisfaction with the visit

This study will recruit patients with presenting problems of prolapse lower urinary tract symptoms or incontinence into one of three arms use of an AI chatbot prior to seeing the urogynecologist use of an AI chatbot following a consult with the urogynecologist no use of an AI chatbot at the time of the visit During time of their initial urogynecology visit data will be collected including demographics Pelvic Floor Disorders Inventory PFDI intake questionnaire data health literacy Chat GPT conversation office consultation diagnosestreatment physician questionnaire and post-consultation questionnaire Diagnosis and Treatment Decisional Conflict Scale Patient Satisfaction Chatbot Satisfaction Patients will be asked three months after their visit to complete the post-consultation questionnaire again

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None